Apnimed to seek approval for sleep apnoea pill after Phase III success
Apnimed will be waiting for the readout from a second Phase III trial before it approaches the FDA with an NDA.
Neurogene introduces gene therapy monitoring system after patient death
Sarepta reports outcomes from trial of Duchenne muscular dystrophy therapy
IQVIA and SCRI partner to enhance oncology trials
Pharma’s AI prospects get nudged into the future with EU’s AI act
Nuance seeks China approval for Ohtuvayre following Phase III trial success
Analysis
View More
Themes
View MoreAI-automated IVF procedures represent a new era in fertility treatment
The future of the field looks promising and could significantly change how families experience fertility treatments.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
1 of 2
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
IoT can help to reduce the burden of clinical trials on patients
Mastering compliance and copyright in healthcare and MedComms
MWC Barcelona 2025: Maximizing 5G network value in the age of AI
Driving bioscience innovation: How Teesside University empowers industry breakthroughs